Company Filing History:
2 out of 24 
1 out of 1,291 
Years Active: 2018-2023
Title: Innovations by Boris Zlatopolskiy
Introduction
Boris Zlatopolskiy is a notable inventor based in Cologne, Germany. He has made significant contributions to the field of medical imaging, particularly in the development of innovative probes for detecting prostate cancer.
Latest Patents
Zlatopolskiy holds two patents that focus on advanced imaging techniques. His first patent involves 2-alkoxy-6-[18F]fluoronicotinoyl substituted lys-c(O)-glu derivatives, which serve as efficient probes for imaging PSMA-expressing tissues. This invention demonstrates superior performance compared to existing PSMA-specific ligands, such as [F]DCFPyL and [Ga]HBED-CC-PSMA. The 2-alkoxy derivative shows higher cellular uptake in prostate tumor cells, while the 4-alkoxy substituted derivative exhibits lower uptake. His second patent describes a method for producing 18F-labeled active esters, which are crucial for creating PSMA-specific PET tracers. These methods are efficient, time-saving, and suitable for automation, enhancing the capabilities of positron emission tomography (PET) imaging.
Career Highlights
Zlatopolskiy has worked with prominent institutions, including the Max Planck Society for the Advancement of Science and the University of Cologne. His work has significantly impacted the field of medical imaging, particularly in the diagnosis of prostate cancer.
Collaborations
He has collaborated with notable colleagues, including Bernd Neumaier and Raphael Richarz, contributing to the advancement of innovative imaging techniques.
Conclusion
Boris Zlatopolskiy is a distinguished inventor whose work in medical imaging has led to the development of groundbreaking technologies for detecting prostate cancer. His contributions continue to influence the field and improve diagnostic capabilities.